# Lynavoy

NDC: 69516-140
Generic name: Linerixibat
Labeler / Manufacturer: Intercept Pharmaceuticals Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20260611

FDA application: NDA220295

## Active ingredients

- LINERIXIBAT: 40 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69516-140"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69516-140
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c00317c8-709c-4707-a6d1-632bff123026